<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1365</article-id><article-id pub-id-type="doi">10.15690/vramn1365</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>PHARMACOLOGY AND PHARMACY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ФАРМАКОЛОГИИ И ФАРМАЦИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Continuity of Chronic Medications in Multimorbid Patients during Perioperative Period: Retrospective Analysis</article-title><trans-title-group xml:lang="ru"><trans-title>Проблема преемственности лекарственной терапии у полиморбидных пациентов в периоперационном периоде: данные ретроспективного анализа.</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8840-4904</contrib-id><contrib-id contrib-id-type="spin">2263-3980</contrib-id><name-alternatives><name xml:lang="en"><surname>Nigmatkulova</surname><given-names>Maria D.</given-names></name><name xml:lang="ru"><surname>Нигматкулова</surname><given-names>Мария Дмитриевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>graduate student, clinical pharmacologist</p></bio><bio xml:lang="ru"><p>аспирант кафедры клинической фармакологии и терапии РМАНПО; врач-клинический фармаколог отдела управления качеством медицинской помощи ММЦ БР</p></bio><email>mnigmatkulova@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8745-6195</contrib-id><contrib-id contrib-id-type="spin">2037-7164</contrib-id><name-alternatives><name xml:lang="en"><surname>Kleymenova</surname><given-names>E. B.</given-names></name><name xml:lang="ru"><surname>Клейменова</surname><given-names>Елена Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>доктор медицинских наук</p></bio><email>e.kleymenova@gmail.com</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1357-0056</contrib-id><contrib-id contrib-id-type="spin">1910-0484</contrib-id><name-alternatives><name xml:lang="en"><surname>Yashina</surname><given-names>Liubov P.</given-names></name><name xml:lang="ru"><surname>Яшина</surname><given-names>Любовь Петровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Biology</p></bio><bio xml:lang="ru"><p>кандидат биологических наук</p></bio><email>lyashina1@yandex.ru</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4496-3680</contrib-id><contrib-id contrib-id-type="spin">4525-7556</contrib-id><name-alternatives><name xml:lang="en"><surname>Sychev</surname><given-names>Dmitry A.</given-names></name><name xml:lang="ru"><surname>Сычев</surname><given-names>Дмитрий Алексеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, член-корр. РАН</p></bio><email>dmitrysychevrmapo@gmail.com</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Medical Academy of Continuing Professional Education</institution></aff><aff><institution xml:lang="ru">Многопрофильный медицинский центр Банка России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">General Medical Center of the Bank of Russia</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного профессионального образования</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">General Medical Center of the Bank of Russia</institution></aff><aff><institution xml:lang="ru">Многопрофильный медицинский центр Банка России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Russian Medical Academy of Continuing Professional Education</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного профессионального образования</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Federal Research Center «Computer Science and Control» of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Федеральный исследовательский центр «Информатика и управление» РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2021</year></pub-date><volume>76</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>210</fpage><lpage>220</lpage><history><date date-type="received" iso-8601-date="2020-06-02"><day>02</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-05-03"><day>03</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Издательство "Педиатръ"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-06-30"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/1365">https://vestnikramn.spr-journal.ru/jour/article/view/1365</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>Failure of continuity at care transitions results in 50% of all medication errors and up to 20% of adverse drug events (ADEs). In surgical patients medication errors occur more often than in medical patients due to perioperative corrections of medications and greater number of in-hospital transitions. The frequency of ADE in surgical patients varies from 2.3 to 27.7%.</p> <p><bold>Aims</bold> — to determine the prevalence and structure of unintentional discrepancies (UDs) in medications at admission to and discharge from surgery departments, report their potential clinical impact and analyse possible risk factors.</p> <p><bold>Methods. </bold>Retrospective observational study was conducted in a general hospital in Russia. The study included patients hospitalized for elective surgery in Surgical Departments from January to June 2019. The pre-admission Best Possible Medication History (BPMH) for every patient was obtained. The BPMHs were compared with admission medication orders and hospital discharge prescriptions to identify UDs. Detected UDs were analysed for potential ADE with severity evaluation.</p> <p><bold>Results.</bold> 206 patients were included, 55.83% were female, mean age 63.85 (±9.38), median of chronic medications was 3 drugs. At least one UD was detected in 70.87% of patients at admission and in 92.72% at discharge, respectively, with averages of 1.30 and 2.81 discrepancies per patient. Cardiovascular drugs were the most frequent class involved at both admission (72.2%) and discharge (68.05%) in UDs. The most often UDs at both admission (51.68%) and discharge (94.65%) were omissions, incorrect dose (22.47% and 2.25%), and additional medications (11.6% and 1.55%). UDs had the potential to cause significant ADEs in 81.27%, serious ADEs in 18.35% of cases. Only 0.37% of UDs could contribute to life-threatening ADEs. The relative risk of discrepancies in patients of 60 years and older was 1.292-fold higher; three and more chronic medications increase risk 1.565-fold; diabetic or thyroid medications increase risk 1.932-fold.</p> <p><bold>Conclusions. </bold>We reported on the first study of medication discrepancies conducted in Russian hospital. Estimated frequency, structure and risk factors of UDs in medications at admission to and discharge from surgery departments are similar to those from other countries. To decrease UDs in medications, implementation of medication reconciliation is needed.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Нарушение преемственности при переводах пациентов является одной из главных причин ошибок при применении лекарственных препаратов (ЛП) и развития до 20% нежелательных лекарственных событий (НЛС). У хирургических пациентов ошибки при применении ЛП возникают чаще, чем у терапевтических. Этому способствуют необходимость коррекции лекарственной терапии в связи с оперативным вмешательством, а также большее количество внутригоспитальных переводов. Частота НЛС у хирургических пациентов варьируется от 2,3 до 27,7%.</p> <p><bold>Цель исследования </bold>— оценить частоту и структуру непреднамеренных расхождений при назначении ЛП для лечения хронических заболеваний, оценить структуру связанных с ними потенциальных НЛС у планово госпитализированных полиморбидных пациентов хирургического профиля, выявить факторы, влияющие на возникновение непреднамеренных расхождений.</p> <p><bold>Методы.</bold> В ретроспективном фармакоэпидемиологическом исследовании, проведенном в 293-коечном многопрофильном стационаре г. Москвы, анализировались данные 206 плановых хирургических госпитализаций за период с 14 января по 30 июня 2019 г. Для каждого пациента составлен список постоянно принимаемых лекарств, который сравнивался с лекарственными назначениями при поступлении, и с ЛП, рекомендованными при выписке из стационара. Непреднамеренные расхождения проанализированы на предмет возникновения потенциальных нежелательных лекарственных событий с оценкой их тяжести.</p> <p><bold>Результаты.</bold> Как минимум, одно непреднамеренное расхождение выявлено у 70,87% пациентов при поступлении в стационар и у 92,72% — при выписке, а среднее количество расхождений на одного пациента составило 1,30 и 2,81 соответственно. В структуре преобладали «потеря» (51,69%), ошибка в дозе (51,69%) и назначение дополнительного ЛП (11,6%). Наиболее часто непреднамеренные расхождения наблюдались при назначении сердечно-сосудистых ЛП (72,2% расхождений при поступлении и 68,05% — при выписке). 81,27% расхождений могли привести к клинически значимым, 18,35% — к серьезным и 0,37% — к жизнеугрожающим НЛС. Факторы, повышающие относительный риск возникновения расхождений: возраст старше 60 лет (RR = 1,292; 95%-й CI: 1,023–1,631), постоянный прием трех и более ЛП (RR = 1,565; 95%-й CI: 1,147–2,134) и прием препаратов для лечения сахарного диабета (СД) и заболеваний щитовидной железы (RR = 1,932; 95%-й CI: 1,047–3,565).</p> <p><bold>Заключение.</bold> Выявленные частота и структура, а также факторы риска непреднамеренных расхождений в лекарственных назначениях у хирургических пациентов необходимы при планировании вмешательств по профилактике НЛС в стационаре.</p></trans-abstract><kwd-group xml:lang="en"><kwd>medication errors</kwd><kwd>medication reconciliation</kwd><kwd>patient safety</kwd><kwd>risk factors</kwd><kwd>surgical departments</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нежелательные лекарственные события</kwd><kwd>сверка лекарственных назначений</kwd><kwd>безопасность пациентов</kwd><kwd>ошибки при назначении лекарств</kwd><kwd>плановые хирургические вмешательства</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский фонд фундаментальных исследований</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Foundation for Basic Research</institution></institution-wrap></funding-source><award-id>19-315-90014</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Institute for Healthcare Improvement. Medication Reconciliation Review. IHI, 2004. 5 р. [assessed: 15 January 2020]. Available from: http://www.ihi.org/resources/Pages/Tools/MedicationReconciliationReview.aspx</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sullivan C, Gleason KM, Rooney D, et al. Medication reconciliation in the acute care setting: Opportunity and challenge for nursing. J Nurs Care Qual. 2005;20(2):95–98. doi: https://doi.org/https://doi.org/10.1097/00001786-200504000-00001</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad Saúde Pública. 2009;25(3):S360–S372. doi: https://doi.org/10.1590/s0102-311x2009001500003</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Joint Commission on Accreditation of Healthcare Organizations. Using medication reconciliation to prevent errors. Jt Comm J Qual Patient Saf. 2006;32(4):230–232. doi: https://doi.org/10.1016/S1553-7250(06)32030-2</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Tam VC, Knowles SR, Cornish PL, et al. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005;173:510–515. doi: https://doi.org/10.1503/cmaj.045311</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. National Institute for Health and Care Excellence. 2020. January 23. Available from: https://www.nice.org.uk/guidance/ng5/chapter/1-Recommendations#medicines-reconciliation</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Medication reconciliation. Australian Commission on Safety and Quality in Healthcare. 2020. January 15. Available from: https://www.safetyandquality.gov.au/our-work/medication-safety/medication-reconciliation</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Canadian Council on Health Services Accreditation. Required Organizational Practices (ROP) Handbook 2017. Version 2. 2020. January 23. Available from: https://accreditation.ca/required-organizational-practices/</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>WHO Collaborating Centre for Patient Safety. The High 5s Project – Standard Operating Protocol for Medication Reconciliation. Assuring Medication Accuracy at Transitions in Care. WHO, 2014. 36 p. [assessed: 21 May 2020]. Available from: https://www.who.int/patientsafety/implementation/solutions/high5s/h5s-sop.pdf</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hospital: 2020 National Patient Safety Goals. Joint Commission on Accreditation of Healthcare Organizations. 2020. May 22. Available from: https://www.jointcommission.org/standards/national-patient-safety-goals/hospital-2020-national-patient-safety-goals/</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Mazhar F, Akram S, Al-Osaimi YA, Haider N. Medication reconciliation errors in a tertiary care hospital in Saudi Arabia: admission discrepancies and risk factors. Pharmacy Practice. 2017;15(1):864. doi: https://doi.org/10.18549/pharmpract.2017.01.864</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Pascual O, Real J, Uriarte M, et al. Evaluation of medication reconciliation in a Trauma Unit. Revista Española de Cirugía Ortopédica y Traumatología. 2015;59:91–96. doi: https://doi.org/10.1016/j.recot.2014.07.003</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Gonzalez-Garcia L, Salmeron-Garcia A, Garcia-Lirola M, et al. Medication reconciliation at admission to surgical departments. J Eval Clin Pract. 2016;22(1):20–25. doi: https://doi.org/10.1111/jep.12403</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Lazarus HM, Fox J, Evans RS, et al. Adverse drug events in trauma patients. J Trauma. 2003;54(2):337–343. doi: https://doi.org/10.1097/01.ta.0000051937.18848.68</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Morimoto T, Sakuma M, Matsui K, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Inter Med. 2011;26(2):148–153. doi: https://doi.org/10.1007/s11606-010-1518-3</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>de Vries EN, Ramrattan MA, Smorenburg SM, et al. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216–223. doi: https://doi.org/10.1136/qshc.2007.023622</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>de Vries EN, Prins HA, Crolla RMPH, et al. Effect of a comprehensive surgical safety system on patient outcomes. N Engl J Med. 2010;363(20):1928–1937. doi: https://doi.org/10.1056/nejmsa0911535</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Roure Nuez C, González Navarro M, González Valdivieso J, et al. Effectiveness of a perioperative chronic medication reconciliation program in patients scheduled for elective surgery. Medicina Clinica (Barc). 2012;139(15):662–667. doi: https://doi.org/10.1016/j.medcli.2012.04.032</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Al-Jazairi AS, Al-Suhaibani LK, Al-Mehizia RA, et al. Impact of a medication reconciliation program on cardiac surgery patients. Asian Cardiovasc Thorac Ann. 2017;25(9):579–585. doi: https://doi.org/10.1177/0218492317738382</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23:1414. doi: https://doi.org/10.1007/s11606-008-0687-9</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Назаренко Г.И., Клейменова Е.Б., Отделенов В.А., и др. Использование триггеров нежелательных событий для выявления побочных реакций при применении лекарственных средств в стационаре // Клиническая фармакология и терапия. — 2015. — Т. 24. — № 4. — С. 55–62. [Nazarenko GI, Kleymenova EB, Otdelenov VA, et al. Ispol’zovanie triggerov nezhelatel’nyh sobytij dlja vyjavlenija pobochnyh reakcij pri primenenii lekarstvennyh sredstv v stacionare. Klinicheskaja Farmakologija i Terapija. 2015;24(4):55–62. (In Russ.)]</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165(4):424–429. doi: https://doi.org/10.1001/archinte.165.4.424</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gleason KM, Groszek JM, Sullivan C, et al. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Amer J Health-System Pharmacy. 2004;61(16):1689–1695. doi: https://doi.org/10.1093/ajhp/61.16.1689</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Mekonnen AB, McLachlan AJ, Brien JA. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis. J Clin. Pharmacy Therap. 2016;41(2):128–144. doi: https://doi.org/10.1111/jcpt.12364</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Cheema E, Alhomoud FK, Kinsara A, et al. The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2018;13(3):e0193510. doi: https://doi.org/10.1371/journal.pone.0193510</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Murphy EM, Oxencis CJ, Klauck JA, et al. Medication reconciliation at an academic medical center: implementation of a comprehensive program from admission to discharge. Am J Health Syst Pharm. 2009;66(23):2126–2131. doi: https://doi.org/10.2146/ajhp080552</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Al-Hashar A, Al-Zakwani I, Eriksson T, et al. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use. Int J Clin Pharm. 2018;40(5):1154–1164. doi: https://doi.org/10.1007/s11096-018-0650-8</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565–571. doi: https://doi.org/10.1001/archinte.166.5.565</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Boockvar KS, Blum S, Kugler A, et al. Effect of admission medication reconciliation on adverse drug events from admission medication changes. Arch Intern Med. 2011;171(9):860–861. doi: https://doi.org/10.1001/archinternmed.2011.163</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003. doi: https://doi.org/10.1136/bmjopen-2015-010003</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Bos JM, Kalkman GA, Groenewoud H, et al. Prediction of clinically relevant adverse drug events in surgical patients. PLoS ONE. 2018;13(8):e0201645. doi: https://doi.org/10.1371/journal.pone.0201645</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ebbens MM, Gombert‐Handoko KB, Al‐Dulaimy M, et al. Risk factors for medication errors at admission in preoperatively screened patients. Pharmacoepidemiol Drug Saf. 2018;27:272–278. doi: https://doi.org/10.1002/pds.4380.</mixed-citation></ref></ref-list></back></article>
